期刊文献+

肝移植术后真菌感染的防治新策略 被引量:9

New strategy of prevention and treatment for fungal infection after liver transplantation
原文传递
导出
摘要 目的探讨肝移植术后病人真菌感染的菌群变化特点和相应的防治策略。方法回顾性分析中山大学附属第三医院肝移植中心2004-2005年485例原位肝移植病人术后真菌感染的流行病学资料和药敏结果。结果485例病人中79例出现术后真菌感染,真菌感染率为16.3%,共分离出菌株88株,其中念珠菌71株(白色念珠菌35株,非白色念珠菌36株),曲霉菌17株,在菌群分布上2004年和2005年差异有显著性(P<0.05)。念珠菌对氟康唑的耐药率2005年(60.0%)较2004年(33.3%)明显上升(P<0.05)。结论肝移植术后非白色念珠菌和曲霉菌感染的比例逐渐上升,临床上应根据分离培养结果选择适当的抗真菌药物。 Objective To investigate the distribution of fungal infection and the corresponding prevention and treatment after liver transplantation. Methods Epidemiology data and susceptibility test of 485 cases of orthotropie liver transplantation were retrospective analyzed between 2004 and 2005. Results 88 fungi strains were isolated in 79 patients and the infection rate was 16. 3%. Among them 71 strains were albicans in which 35 strains Candida albieans and 36 strains other Candida albieans, 17 strains were aspergillus. There was significant difference in the distribution of fungi between 2004 and 2005 ( P 〈 0. 05). The resistence of albieans to flueonazole in 2005 (60%) was significantly higher than that in 2004 (33.3%)( P 〈0. 05). Conclusion The percentage of other Candida albicans and aspergillys is increasing, We should select appropriate anti-fungal drug according to the cultivation.
出处 《中国实用外科杂志》 CSCD 北大核心 2007年第1期78-80,共3页 Chinese Journal of Practical Surgery
基金 国家科技部973计划项目(2003CB515500) 广东省自然科学基金(4105344) 广州市科技计划项目资助(2005Z3-E0101)
关键词 肝移植 真菌感染 流行病学 Liver transplantation Fungal infection Epidemiology
  • 相关文献

参考文献8

  • 1Losada I,Cuervas-Mons V,Milan I,et al.Early infection in liver transplant cipients:incidense,severity,risk factors and antibiotic sensitivity of bacterial isolates[J].Enferm Infect Microbiol Clin,2002,20(9):419 -421.
  • 2Fung JJ.Fungal infection in liver transplantation[J].Transpl Infect Dis,2002,Suppl3:S18-S23.
  • 3Greig P,Lilly L,Scudamroe C,et al.Early steroid withdrawl after liver transplantation:the Canadian tracrolimus versus microemulsion cyclosporine A trial:l year follow up[J].Liver Transplant,2003,9(6):587 -595.
  • 4汤耀卿.外科病人合并系统性真菌感染的经验性治疗[J].中国实用外科杂志,2004,24(6):328-331. 被引量:11
  • 5Winston PJ,Pakrasi A,Busutil RB.Prophylactic fluconazole in liver transplant recipients:a randomized,double-blind,placebocontrolled trial[J].Ann Intern Med,1999,131 (10):729 -737.
  • 6Linden PK,Coley K,Fontes P,et al.Invasive aspergillosis in liver transplant recipients:outcome comparison of therapy with amphoterician B lipid complex and a historical cohort treatee with conventional amphoterician B[J].Clin Infect Dis,2003,37(1):17-25.
  • 7张坚磊,王金良.深部真菌耐药性的研究进展[J].国外医学(临床生物化学与检验学分册),2005,26(9):609-611. 被引量:14
  • 8Herbrecht R,Denning DW,Patterson TF,et al.Foriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J].N Engl J Med,2002,347(6):408 -414.

二级参考文献32

  • 1Pound MW, Drew RH, Perfect JR.Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumonia.Curr Opin Infect Dis,2002,15(2):183-194.
  • 2Granier F. Invasive fungal infections.Epidemiology and new therapies. Presse Med, 2000,29 (37):2051-2056.
  • 3Stone EA,Fung HB,Kirschenbaum HL.Caspofungin: an echinocandin antifungal agent.Clin Ther, 2002,24(3):351-377;discussion 329.
  • 4Ilex JH, Pdnald MG. Resistance of Candida species to flueonazole. Amimicrob Agents Chemoter, 1995,39(1):1.
  • 5Matar MJ, Ostrosky-Zeichner L, Paetznick VL, et al. Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole.Antimicrobial Agents and Chemotherapy, 2003, 47(5): 1647-1651.
  • 6White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998,11(2): 382-402.
  • 7Alexander BD, Perfect JR. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. Drugs, 1997,54(5):657-678.
  • 8Bemhardt H, Zimmermann K, Knoke M, et al. Fungal resistance . Infection, 1999,27(Suppl 2) :S52.
  • 9Nolte FS, Parkinson T, Falconer DJ, et al. Isolation and charactetization of fiuconazole and amphoteficin B resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother, 1997,41 (1):196-199.
  • 10Lyons CN, White TC. Transcriptional analyses of antifungal drug resistance in Candida albicans. Anbimicrob Agents Chemother, 2000,44(9):2296-2303.

共引文献23

同被引文献94

引证文献9

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部